CeCors Inc
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $0.016
- Today's High:
- $0.018
- Open Price:
- $0.018
- 52W Low:
- $0.0101
- 52W High:
- $0.0977
- Prev. Close:
- $0.017
- Volume:
- 46326
Company Statistics
- Market Cap.:
- $14466
- Book Value:
- -0.016
- Revenue TTM:
- $0
- Operating Margin TTM:
- 0%
- Gross Profit TTM:
- $0
- Profit Margin:
- 0%
- Return on Assets TTM:
- -179.72%
- Return on Equity TTM:
- -726.1%
Company Profile
CeCors Inc had its IPO on under the ticker symbol CEOS.
The company operates in the Healthcare sector and Medical Instruments & Supplies industry. CeCors Inc has a staff strength of 6 employees.
Stock update
Shares of CeCors Inc opened at $0.02 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $0.02 - $0.02, and closed at $0.02.
This is a -5.88% slip from the previous day's closing price.
A total volume of 46,326 shares were traded at the close of the day’s session.
In the last one week, shares of CeCors Inc have slipped by -10.61%.
CeCors Inc's Key Ratios
CeCors Inc has a market cap of $14466, indicating a price to book ratio of 0 and a price to sales ratio of 0.
In the last 12-months CeCors Inc’s revenue was $0 with a gross profit of $0 and an EBITDA of $-3721240. The EBITDA ratio measures CeCors Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, CeCors Inc’s operating margin was 0% while its return on assets stood at -179.72% with a return of equity of -726.1%.
In Q3, CeCors Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.
CeCors Inc’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
Its diluted EPS in the last 12-months stands at $-12.83 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into CeCors Inc’s profitability.
CeCors Inc stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of -0.0195. Its price to sales ratio in the trailing 12-months stood at 0.
CeCors Inc stock pays annual dividends of $0 per share, indicating a yield of 4.24% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $197183.00
- Total Liabilities
- $342563.00
- Operating Cash Flow
- $0
- Capital Expenditure
- $0
- Dividend Payout Ratio
- 0%
CeCors Inc ended 2024 with $197183.00 in total assets and $0 in total liabilities. Its intangible assets were valued at $197183.00 while shareholder equity stood at $-210441.00.
CeCors Inc ended 2024 with $0 in deferred long-term liabilities, $342563.00 in other current liabilities, 12868.00 in common stock, $-33909494.00 in retained earnings and $0 in goodwill. Its cash balance stood at $57422.00 and cash and short-term investments were $0. The company’s total short-term debt was $130,973 while long-term debt stood at $65061.00.
CeCors Inc’s total current assets stands at $113889.00 while long-term investments were $0 and short-term investments were $0. Its net receivables were $0 compared to accounts payable of $140167.00 and inventory worth $0.
In 2024, CeCors Inc's operating cash flow was $0 while its capital expenditure stood at $0.
Comparatively, CeCors Inc paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $0.02
- 52-Week High
- $0.0977
- 52-Week Low
- $0.0101
- Analyst Target Price
- $
CeCors Inc stock is currently trading at $0.02 per share. It touched a 52-week high of $0.0977 and a 52-week low of $0.0977. Analysts tracking the stock have a 12-month average target price of $.
Its 50-day moving average was $0.03 and 200-day moving average was $0.04 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 0% of the company’s stock are held by insiders while 0% are held by institutions.
Frequently Asked Questions About CeCors Inc
Similar Industry Stocks (Medical Instruments & Supplies)
Most Active
Top Gainers
Top Losers
About
Psykey, Inc. engages in the research, development, and commercialization of entheogenic, adaptogenic, and nootropic ingredients and formulations for its functional product lines to improve and optimize life. The company also engages in the development of technologies for the composition, bioavailability, and targeted delivery of entheogen-based therapeutics for the psychedelic market. Its retail products include functional mushroom coffees and teas, oral supplements, and single serve drink mixes. The company was formerly known as CeCors, Inc. and changed its name to Psykey, Inc. in August 2021. Psykey, Inc. was founded in 2002 and is based in Toronto, Canada.